Please turn JavaScript on
StockStory icon

StockStory

Get updates from StockStory via email, on your phone or read them on follow.it on your own custom news page.

You can filter the news from StockStory that get delivered to you using tags or topics or you can opt for all of them. Unsubscription is also very simple.

See the latest news from StockStory below.

Site title: StockStory

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  94.5 / day

Message History

What Happened?

Shares of infrastructure equipment supplier SPX Technologies (NYSE:SPXC) jumped 13.7% in the afternoon session after the company reported strong second-quarter results that beat Wall Street expectations and raised its full-year outlook. 

The infrastructure equipment supplier announced revenue of $679 million, up 22.9% year over year and comfort...


Read full story

What Happened?

Shares of industrial manufacturer Standex (NYSE:SXI) jumped 5.2% in the afternoon session after the company reported second-quarter results that surpassed Wall Street's expectations for revenue and profit. 

The company's sales increased 2.8% year-over-year to $228.3 million, and its adjusted earnings per share came in at $2.45, beating consens...


Read full story

What Happened?

Shares of power generation products company Generac (NYSE:GNRC) jumped 2.5% in the afternoon session after the company posted strong second-quarter results, highlighting significant demand from data center customers. 

The power equipment specialist reported Q2 revenue of $1.17 billion and earnings per share of $2.44. A key driver was its comme...


Read full story

What Happened?

Shares of bitcoin development company Strategy (NASDAQ:MSTR) fell 4.5% in the afternoon session after the company reported a massive second-quarter 2026 earnings miss driven almost entirely by the volatility of its cryptocurrency holdings. 

While the company's core software business met analyst expectations with revenue growing 6.9% year-over-y...


Read full story

What Happened?

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 46.1% in the afternoon session after the company reported disappointing second-quarter 2026 results that missed Wall Street's expectations and included a reduced full-year forecast. 

Revenue for the quarter came in at $190.7 million, down 10.5% year-over-year, falling short o...


Read full story